未归类页面
来自医学百科
下面显示区间#2,601至#2,650的50条结果。
查看（前50个 | 后50个）（20 | 50 | 100 | 250 | 500）
- Tibsovo
- Tifcemalimab
- Tirabrutinib
- Tiragolumab
- Tisagenlecleucel
- Tislelizumab
- Tisotumab vedotin-tftv
- Tivantinib
- Tivozanib
- Tocilizumab
- Tofacitinib
- Tolebrutinib
- Toll样受体
- Toll样受体3
- Toll样受体4
- Tomivosertib
- Top 0.1%
- Top 1%
- Topiroxostat
- Topotecan
- Toripalimab
- Torisel
- Torkinib
- Tositumomab
- Toxicology
- Trabectedin
- Transcriptomics
- Trastuzumab
- Trastuzumab deruxtecan
- Trastuzumab duocarmazine
- Trastuzumab emtansine
- Treg细胞
- Tremelimumab
- Trifluridine-tipiracil
- Trodelvy
- Trop2
- Truseltiq
- Tucatinib
- Tugonertinib
- Tukysa
- Tuoyi
- Turalio
- Tusamitamab
- Tusamitamab ravtansine
- Tykerb
- Tyrphostin AG 1296
- Tyvyt
- T细胞
- T细胞淋巴瘤
- T细胞耗竭